2m 2m 2m 2m 2m 2m 2m
VIRIDIAN THERAPT (VRDN)
NASDAQ
$17.59-$0.04 (-0.26%)
Price as of Jun 23, 2026 6:17 PM EDT- $1.9BMarket Cap
- 19.85%1-Year Change
- BiotechnologyIndustry
VIRIDIAN THERAPT (VRDN)
$17.59-$0.04 (-0.26%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 17.09% | 15.4M | +994,921 (+6.47%) | Mar 31, 2026 |
BLACKROCK, INC. | 8.70% | 7.8M | +1.4M (+17.87%) | Mar 31, 2026 |
BELLEVUE GROUP AG | 7.47% | 6.7M | +2.4M (+35.20%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 6.40% | 5.8M | +954,571 (+16.58%) | Dec 31, 2024 |
VANGUARD GROUP INC | 6.24% | 5.6M | +1.3M (+22.81%) | Dec 31, 2025 |
BLACKROCK INC. | 5.30% | 4.8M | +960,992 (+20.13%) | Jun 30, 2024 |
STATE STREET CORP | 5.19% | 4.7M | +1.2M (+25.82%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 4.52% | 4.1M | +353,135 (+8.69%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 4.25% | 3.8M | -95,600 (-2.50%) | Feb 28, 2026 |
FIDELITY ADVISOR SERIES VII | 3.65% | 3.3M | -100,000 (-3.05%) | Jan 31, 2026 |
iSHARES TRUST | 3.33% | 3.0M | -29,711 (-0.99%) | Mar 31, 2026 |
SPDR SERIES TRUST | 2.96% | 2.7M | +1.0M (+38.03%) | Mar 31, 2026 |
FIDELITY SECURITIES FUND | 2.94% | 2.6M | +154,269 (+5.83%) | Jan 31, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 1.16% | 1.0M | -10,152 (-0.97%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions1.2B (82.70%)
- Mutual Funds230.5M (16.10%)
- Insiders17.1M (1.20%)
- Other0 (0.00%)
Insider Transactions
- 1.20% (17.1M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $76.1MAmount of InsiderBuying (last 12 months)
- 1Number of InsiderSelling (last 12 months)
- $70,795.52Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Beetham Thomas W. Chief Operating Officer | Exempt | Mar 03, 2026 | $0.00 | 9,409 | $0.00 | 28,227 |
Mahoney Stephen F. President and CEO | Exempt | Mar 03, 2026 | $0.00 | 18,357 | $0.00 | 55,071 |
Harmon Seth Chief Financial Officer | Exempt | Mar 03, 2026 | $0.00 | 6,267 | $0.00 | 18,801 |
Mahoney Stephen F. President and CEO | Exempt | Mar 03, 2026 | $0.00 | 18,357 | $0.00 | 40,757 |
Beetham Thomas W. Chief Operating Officer | Exempt | Mar 03, 2026 | $0.00 | 9,409 | $0.00 | 16,409 |
Mahoney Stephen F. President and CEO | In Kind | Mar 03, 2026 | $223,623.64 | 7,627 | $29.32 | 33,130 |
Harmon Seth Chief Financial Officer | Exempt | Mar 03, 2026 | $0.00 | 6,267 | $0.00 | 9,881 |
Beetham Thomas W. Chief Operating Officer | In Kind | Mar 03, 2026 | $92,006.16 | 3,138 | $29.32 | 13,271 |
Harmon Seth Chief Financial Officer | In Kind | Mar 03, 2026 | $61,308.12 | 2,091 | $29.32 | 7,790 |
Tousignant Jennifer Chief Legal Officer | Exempt | Mar 03, 2026 | $0.00 | 5,169 | $0.00 | 15,510 |
Tousignant Jennifer Chief Legal Officer | Exempt | Mar 03, 2026 | $0.00 | 5,169 | $0.00 | 5,169 |
Tousignant Jennifer Chief Legal Officer | In Kind | Mar 03, 2026 | $50,547.68 | 1,724 | $29.32 | 3,445 |
Mahoney Stephen F. President and CEO | Award | Mar 02, 2026 | $0.00 | 559,600 | $0.00 | 559,600 |
Tripuraneni Radhika Chief Medical Officer | Award | Mar 02, 2026 | $0.00 | 95,800 | $0.00 | 95,800 |
Mahoney Stephen F. President and CEO | Award | Mar 02, 2026 | $0.00 | 111,900 | $0.00 | 111,900 |
Harmon Seth Chief Financial Officer | Award | Mar 02, 2026 | $0.00 | 102,850 | $0.00 | 102,850 |
Tripuraneni Radhika Chief Medical Officer | Award | Mar 02, 2026 | $0.00 | 19,150 | $0.00 | 19,150 |
Beetham Thomas W. Chief Operating Officer | Award | Mar 02, 2026 | $0.00 | 176,550 | $0.00 | 176,550 |
Harmon Seth Chief Financial Officer | Award | Mar 02, 2026 | $0.00 | 20,550 | $0.00 | 20,550 |
Beetham Thomas W. Chief Operating Officer | Award | Mar 02, 2026 | $0.00 | 35,300 | $0.00 | 35,300 |
Tousignant Jennifer Chief Legal Officer | Award | Mar 02, 2026 | $0.00 | 119,300 | $0.00 | 119,300 |
Tousignant Jennifer Chief Legal Officer | Award | Mar 02, 2026 | $0.00 | 23,850 | $0.00 | 23,850 |
Tousignant Jennifer Chief Legal Officer | Sell | Dec 31, 2025 | $70,795.52 | 2,272 | $31.16 | 0 |
Fairmount Funds Management LLC | Buy | Oct 23, 2025 | $10.0M | 454,545 | $22.00 | 3.9M |
Ajer Jeffrey Robert | Award | Jul 01, 2025 | $0.00 | 21,000 | $0.00 | 21,000 |
CAIN CHRISTOPHER W. | Award | Jul 01, 2025 | $0.00 | 21,000 | $0.00 | 21,000 |
Kiselak Tomas | Award | Jul 01, 2025 | $0.00 | 21,000 | $0.00 | 21,000 |
Gheuens Sarah | Award | Jul 01, 2025 | $0.00 | 21,000 | $0.00 | 21,000 |
Morris Arlene | Award | Jul 01, 2025 | $0.00 | 21,000 | $0.00 | 21,000 |
Ajer Jeffrey Robert | Award | Apr 07, 2025 | $0.00 | 42,000 | $0.00 | 42,000 |